Logo image of OLK

OLINK HOLDING AB - ADR (OLK) Stock Price, Quote, News and Overview

NASDAQ:OLK - Nasdaq - US6807101000 - ADR - Currency: USD

26.08  +0.08 (+0.31%)

After market: 26.02 -0.06 (-0.23%)

OLK Quote, Performance and Key Statistics

OLINK HOLDING AB - ADR

NASDAQ:OLK (7/9/2024, 9:30:55 PM)

After market: 26.02 -0.06 (-0.23%)

26.08

+0.08 (+0.31%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High26.09
52 Week Low14.1
Market Cap3.24B
Shares124.34M
Float41.90M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PE516.44
Earnings (Next)08-07 2024-08-07/amc
IPO03-25 2021-03-25


OLK short term performance overview.The bars show the price performance of OLK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10

OLK long term performance overview.The bars show the price performance of OLK in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 60 80

The current stock price of OLK is 26.08 USD. In the past month the price increased by 5.8%. In the past year, price increased by 32.12%.

OLINK HOLDING AB - ADR / OLK Daily stock chart

OLK Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 18.33 151.57B
DHR DANAHER CORP 25.84 137.80B
A AGILENT TECHNOLOGIES INC 20.88 32.15B
IQV IQVIA HOLDINGS INC 12.61 24.65B
MTD METTLER-TOLEDO INTERNATIONAL 28.7 24.13B
WAT WATERS CORP 29.32 20.78B
WST WEST PHARMACEUTICAL SERVICES 31.85 15.19B
ILMN ILLUMINA INC 24.59 12.96B
TEM TEMPUS AI INC N/A 10.83B
RVTY REVVITY INC 18.41 10.70B
ICLR ICON PLC 9.63 10.50B
QGEN QIAGEN N.V. 19.7 9.81B

About OLK

Company Profile

OLK logo image Olink Holding AB provides accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. The company is headquartered in Uppsala, Uppsala and currently employs 707 full-time employees. The firm offers a technique to identify actionable biomarkers, with a focus on the human plasma proteome. The firm operates in Sweden and the USA.

Company Info

OLINK HOLDING AB - ADR

Salagatan 16F

Uppsala UPPSALA 75183 SE

CEO: Jon Heimer

Employees: 707

OLK Company Website

Phone: 46184443970

OLINK HOLDING AB - ADR / OLK FAQ

What is the stock price of OLINK HOLDING AB - ADR today?

The current stock price of OLK is 26.08 USD. The price increased by 0.31% in the last trading session.


What is the ticker symbol for OLINK HOLDING AB - ADR stock?

The exchange symbol of OLINK HOLDING AB - ADR is OLK and it is listed on the Nasdaq exchange.


On which exchange is OLK stock listed?

OLK stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for OLINK HOLDING AB - ADR stock?

11 analysts have analysed OLK and the average price target is 26.52 USD. This implies a price increase of 1.69% is expected in the next year compared to the current price of 26.08. Check the OLINK HOLDING AB - ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is OLINK HOLDING AB - ADR worth?

OLINK HOLDING AB - ADR (OLK) has a market capitalization of 3.24B USD. This makes OLK a Mid Cap stock.


How many employees does OLINK HOLDING AB - ADR have?

OLINK HOLDING AB - ADR (OLK) currently has 707 employees.


What are the support and resistance levels for OLINK HOLDING AB - ADR (OLK) stock?

OLINK HOLDING AB - ADR (OLK) has a support level at 25.89 and a resistance level at 26.09. Check the full technical report for a detailed analysis of OLK support and resistance levels.


Is OLINK HOLDING AB - ADR (OLK) expected to grow?

The Revenue of OLINK HOLDING AB - ADR (OLK) is expected to grow by 13.93% in the next year. Check the estimates tab for more information on the OLK EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy OLINK HOLDING AB - ADR (OLK) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does OLINK HOLDING AB - ADR (OLK) stock pay dividends?

OLK does not pay a dividend.


When does OLINK HOLDING AB - ADR (OLK) report earnings?

OLINK HOLDING AB - ADR (OLK) will report earnings on 2024-08-07, after the market close.


What is the Price/Earnings (PE) ratio of OLINK HOLDING AB - ADR (OLK)?

OLINK HOLDING AB - ADR (OLK) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.27).


OLK Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to OLK. When comparing the yearly performance of all stocks, OLK is one of the better performing stocks in the market, outperforming 86.3% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

OLK Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to OLK. OLK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OLK Financial Highlights

Over the last trailing twelve months OLK reported a non-GAAP Earnings per Share(EPS) of -0.27. The EPS decreased by -145.45% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -6.21%
ROE -7.3%
Debt/Equity 0.05
Chartmill High Growth Momentum
EPS Q2Q%-18.18%
Sales Q2Q%4.71%
EPS 1Y (TTM)-145.45%
Revenue 1Y (TTM)18.16%

OLK Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 49% to OLK. The Buy consensus is the average rating of analysts ratings from 11 analysts.

For the next year, analysts expect an EPS growth of 39.4% and a revenue growth 13.93% for OLK


Ownership
Inst Owners0.72%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts49.09
Price Target26.52 (1.69%)
EPS Next Y39.4%
Revenue Next Year13.93%